Health ❯Healthcare ❯Pharmaceuticals ❯Drug Development
Pharmaceuticals Clinical Research Cost of Illness Patient Care Neurology Clinical Trials Public Health Dementia Medical Treatments
The TGA has approved the groundbreaking drug for early-stage Alzheimer’s patients, offering hope for slowing cognitive decline, though high costs and safety protocols limit access.
